Can 'Buy American’ Executive Order Shake Up ‘Dickensian’ Manufacturing Dynamics?
Executive Summary
The Trump administration’s move to strengthen domestic manufacture of essential medicines raises a lot of questions – and industry’s ire.
You may also be interested in...
US COVID-19 Relief Package Boosts Pharma Manufacturing Programs – More To Come?
$10bn here and $6bn there on top of what’s left from earlier CARES Act gives government more options on COVID-19 medical countermeasures.
US COVID-19 Relief Law Boosts Pharmaceutical Manufacturing Programs; Is More To Come?
$10bn here and $6bn there on top of what’s left from earlier CARES Act gives government more options on COVID-19 medical countermeasures.
Biden Launches Effort To Strengthen US Pharmaceutical Supply Chain
A fresh executive order from US president Joe Biden calls for short-term and long-term study, broad consultation, and co-ordination with allies on the domestic supply chain.